Use of viscoelastic coagulation testing to monitor low molecular weight heparin administration to healthy horses
- 8 May 2013
- journal article
- research article
- Published by Wiley in Journal of Veterinary Emergency and Critical Care
- Vol. 23 (3) , 291-299
Abstract
Objectives: To evaluate the utility of thromboelastography (TEG) and Sonoclot analyses to monitor the effects of low molecular weight heparin (LMWH) administration to healthy horses.Design: Randomized crossover study.Setting: Large animal veterinary teaching hospital.Animals: Six adult mixed breed healthy mares.Interventions: LMWH (dalteparin) was administered (50 U/kg subcutaneously) either every 12 or 24 h for 3 consecutive days. Blood samples were collected before LMWH administration and then at selected time points for analysis. Thromboelastography derived R‐time (R), K‐time (K), angle (ANG), and maximum amplitude (MA), and Sonoclot activated clot time (ACT), clot rate (CR), and platelet function (PF) were measured in whole blood 30 min after sample collection. Change (Δ) and percentage change (%Δ) from baseline of each TEG and Sonoclot variable were subsequently calculated. Anti‐factor Xa activity and activated partial thromboplastin time (aPTT) were assayed in harvested plasma. The association between anti‐factor Xa activity and TEG and Sonoclot (measured and calculated) variables was assessed by calculating correlation coefficients and multiple regression analysis. The ability of measured and calculated TEG and Sonoclot variables to predict when anti‐factor Xa activity fell below suggested thromboprophylactic levels was assessed using receiver operating characteristic curve analysis.Measurements and Main Results: The correlation between aPTT and anti‐factor Xa activity was weak (r= 0.343). Changes in TEG and Sonoclot variables following LMWH administration were consistent with hypocoagulation. All measured and calculated TEG variables were significantly correlated with anti‐factor Xa activity. Sonoclot ACT, ΔACT, CR, ΔCR, and %ΔCR were also significantly correlated with anti‐factor Xa activity. TEG ΔR and %ΔR best predicted anti‐factor Xa activity below the suggested thromboprophylactic level.Conclusions: Although correlations were modest, serial measurement of TEG variables may be used to monitor LMWH therapy in horses; however, further research is required in sick horses.Keywords
This publication has 37 references indexed in Scilit:
- Thromboelastography in healthy, sick non‐septic and septic neonatal foalsAustralian Veterinary Journal, 2011
- Thromboelastography in healthy horses and horses with inflammatory gastrointestinal disorders and suspected coagulopathiesJournal of Veterinary Emergency and Critical Care, 2010
- Low-Molecular-Weight Heparin Dosage in Newborn FoalsJournal of Veterinary Internal Medicine, 2010
- The effect of unfractionated heparin on thrombelastographic analysis in healthy dogsJournal of Veterinary Emergency and Critical Care, 2010
- Do neonates, infants and young children need a higher dose of enoxaparin in the cardiac intensive care unit?Cardiology in the Young, 2010
- Thrombelastography Versus AntiFactor Xa Levels in the Assessment of Prophylactic-Dose Enoxaparin in Critically Ill PatientsJournal of Trauma: Injury, Infection & Critical Care, 2009
- Coagulopathy of the critically ill equine patientJournal of Veterinary Emergency and Critical Care, 2009
- Thrombelastography in 26 healthy horses with and without activation by recombinant human tissue factorJournal of Veterinary Emergency and Critical Care, 2009
- Impact of Sonoclot hemostasis analysis after cardiopulmonary bypass on postoperative hemorrhage in cardiac surgeryJournal of Anesthesia, 2007
- Usefulness of Thrombelastography for Dosage Monitoring of Low Molecular Weight Heparin and Unfractionated Heparin During HemodialysisArtificial Organs, 1990